Weiss Multi Strategy Advisers LLC Chemo Centryx, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

  • $0
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$22.17 - $51.8 $1.52 Million - $3.55 Million
68,471 Added 684.37%
78,476 $4.05 Million
Q2 2022

Aug 15, 2022
BUY
$15.36 - $27.51 $153,676 - $275,237
10,005 New
10,005 $248,000
Q4 2021

Feb 14, 2022
SELL
$18.38 - $40.5 $459,500 - $1.01 Million
-25,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$13.18 - $19.83 $329,500 - $495,749
25,000 New
25,000 $428,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email